World's Best Scientists 2026 revealed!
Bernard M. J. Uitdehaag

Bernard M. J. Uitdehaag

D-Index & Metrics

Medicine

D-Index
90
Citations
39255
World Ranking
12034
National Ranking
465

Bernard M. J. Uitdehaag publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bernard M. J. Uitdehaag sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 432 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bernard M. J. Uitdehaag D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bernard M. J. Uitdehaag sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bernard M. J. Uitdehaag is affiliated with Amsterdam UMC in the Netherlands and has focused their research career primarily on medicine, with a notable emphasis on multiple sclerosis and related neurological conditions. Their extensive publication record reflects deep engagement with both clinical and epidemiological aspects of neurological diseases and autoimmune disorders.

Their main fields of study include:

  • Medicine

Their work spans several specialized subfields, such as:

  • Pathology and Forensic Medicine
  • Neurology
  • Rheumatology
  • Oncology
  • Epidemiology

Bernard M. J. Uitdehaag's research contributions cover multiple topics, particularly focusing on:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and related diseases
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Peripheral Neuropathies and Disorders
  • Functional Brain Connectivity Studies
  • Neurogenesis and neuroplasticity mechanisms

The scientist has authored or co-authored papers published in various journals. Frequent publication venues include:

  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Journal of Neurology
  • Neurology
  • NeuroImage Clinical

Several notable recent papers authored or co-authored by Bernard M. J. Uitdehaag include:

  • "Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition" (2020), published in Multiple Sclerosis Journal
  • "Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial" (2021), published in The Lancet Neurology
  • "Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm" (2020), published in Annals of Neurology
  • "Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic" (2021), published in Multiple Sclerosis Journal
  • "Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study" (2020), published in CNS Drugs

Frequent collaborators include:

  • Eva Strijbis
  • Frederik Barkhof
  • Joep Killestein
  • Menno M. Schoonheim
  • Brigit A. de Jong

Best Publications

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.

    Clare Walton;Rachel King;Lindsay Rechtman;Wendy Kaye

  • Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

    Philip L De Jager;Philip L De Jager;Xiaoming Jia;Joanne Wang;Paul I W de Bakker

  • Exercise therapy for multiple sclerosis

    Marc B. Rietberg;Dina Brooks;Bernard M.J. Uitdehaag;Gert Kwakkel

  • PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

    G Francis;R Hughes;J King;P Mitchell

  • Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis.

    Rosa E. Boeschoten;Rosa E. Boeschoten;Annemarie M.J. Braamse;Annemarie M.J. Braamse;Aartjan T.F. Beekman;Aartjan T.F. Beekman;Pim Cuijpers

  • Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

    Daniel D Mikol;Frederik Barkhof;Peter Chang;Patricia K Coyle

  • Intracortical Lesions in Multiple Sclerosis: Improved Detection with 3D Double Inversion-Recovery MR Imaging

    Jeroen J. G. Geurts;Petra J. W. Pouwels;Bernard M. J. Uitdehaag;Chris H. Polman

  • Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.

    I. Huitinga;N. Van Rooijen;C. J. A. De Groot;B. M. J. Uitdehaag

  • Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

    Sergio E. Baranzini;Joanne Wang;Rachel A. Gibson;Nicholas Galwey

  • Multiple Sclerosis: Current Knowledge and Future Outlook

    Christian Philipp Kamm;Bernard M. Uitdehaag;Chris H. Polman

  • Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

    Sergio E. Baranzini;Nicholas W. Galwey;Joanne Wang;Pouya Khankhanian

  • Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

    Fred Lublin;David H Miller;Mark S Freedman;Bruce A C Cree

  • Brain atrophy and lesion load predict long term disability in multiple sclerosis

    Veronica Popescu;Federica Agosta;Hanneke E Hulst;Ingrid C Sluimer

  • Progression of regional grey matter atrophy in multiple sclerosis.

    Arman Eshaghi;Arman Eshaghi;Razvan V Marinescu;Alexandra L Young;Nicholas C Firth

  • Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS

    L. Kappos;A. Traboulsee;C.S. Constantinescu;J.P. Eralinna

  • Surgical treatment options for carpal tunnel syndrome

    Rob J.P.M. Scholten;A. Mink Van Der Molen;B. M.J. Uitdehaag;L. M. Bouter

  • Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI

    J.J.G. Geurts;S.D. Roosendaal;M. Calabrese;O. Ciccarelli

  • Bright light treatment in elderly patients with nonseasonal major depressive disorder: A randomized placebo-controlled trial.

    Ritsaert Lieverse;Eus J. W. Van Someren;Marjan M. A. Nielen;Bernard M. J. Uitdehaag

  • Safety, tolerability, and efficacy of orally administered cannabinoids in MS

    J. Killestein;E. L.J. Hoogervorst;M. Reif;N. F. Kalkers

Frequent Co-Authors

Chris H. Polman
Chris H. Polman VU University Medical Center
Frederik Barkhof
Frederik Barkhof University College London
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Jeroen J. G. Geurts
Jeroen J. G. Geurts Vrije Universiteit Amsterdam
Axel Petzold
Axel Petzold University College London
Dirk L. Knol
Dirk L. Knol VU University Medical Center
Mike P. Wattjes
Mike P. Wattjes Hannover Medical School
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Prejaas Tewarie
Prejaas Tewarie University of Twente

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to many healthcare careers beyond the traditional MD path. Many students look for easy nursing programs to get into as a direct route into patient care. These programs may offer more accessible admissions compared to medical schools.

For those interested in the administrative side, medical billing and coding schools online provide training for essential roles in healthcare management. These online options are flexible and often available with financial aid to support your studies.

If entrance exams are a concern, some choose a nursing school without teas test requirements, making the application process simpler for aspiring nurses.

Another great option is an online healthcare administration degree. These accelerated programs help students quickly transition into leadership or management roles in hospitals, clinics, and other medical settings.

Best Scientists Citing Bernard M. J. Uitdehaag

Trending Scientists

Recently Published Articles